ETX2514 is a broad-spectrum β-lactamase inhibitor for the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumannii

TF Durand-Réville, S Guler, J Comita-Prevoir… - Nature …, 2017 - nature.com
Multidrug-resistant (MDR) bacterial infections are a serious threat to public health. Among
the most alarming resistance trends is the rapid rise in the number and diversity of β …
被引用次数：246 相关文章

ETX2514 is a broad-spectrum [beta]-lactamase inhibitor for the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumannii

TF Durand-réville, S Guler, J Comita-prevoir… - Nature …, 2017 - search.proquest.com
Multidrug-resistant (MDR) bacterial infections are a serious threat to public health. Among
the most alarming resistance trends is the rapid rise in the number and diversity of β …

ETX2514 is a broad-spectrum β-lactamase inhibitor for the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumannii

TF Durand-Réville, S Guler… - Nature …, 2017 - pubmed.ncbi.nlm.nih.gov
Multidrug-resistant (MDR) bacterial infections are a serious threat to public health. Among
the most alarming resistance trends is the rapid rise in the number and diversity of β …

ETX2514 is a broad-spectrum β-lactamase inhibitor for the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumannii.

TF Durand-Réville, S Guler, J Comita-Prevoir… - Nature …, 2017 - europepmc.org
Multidrug-resistant (MDR) bacterial infections are a serious threat to public health. Among
the most alarming resistance trends is the rapid rise in the number and diversity of β …